 BEDFORD, Mass.--BUSINESS WIRE--Stoke Therapeutics, Inc., Nasdaq: STOK, a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the Barclays Global Healthcare Conference on Thursday, March 11, 2021, at 3:35 p.m. ET. A live audio webcast of the presentation will be available on the Investors Media section of Stok 